knowledge -WSS

knowledge

author：leisure time 2025-08-12 06:44:39 - browse：37197

Bob Kocher, a partner at venture capital firm Venrock, speaking at STAT's Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

SAN FRANCISCO — Health tech investor Bob Kocher has seen some bad AI-related startup pitches in his time. The worst typically involve AI chatbots masquerading as romantic partners to improve people’s mental health.

“They pitch it to me as a mental health improvement model,” Kocher, a partner at venture capital firm Venrock, said. “If you’re sad, anxious, or depressed, why bother with people?”

Kocher, who is also a doctor and helped write the Affordable Care Act as an Obama administration health official, shared his thoughts on the biggest questions facing digital health at STAT’s Breakthrough Summit on Thursday. Besides sharing a peek inside his generative AI pitch-filled inbox, Kocher talked about cybersecurity vulnerabilities in health systems and venture capitalists buying hospitals.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Why depression after traumatic brain injury is distinct

WSS

Ebola: Gilead Sciences antiviral shows promise as new treatment

A Q&A with Aletha Maybank, AMA’s chief health equity officer

RSV vaccines may be linked to small increased risk of developing GBS

An inside look at PIPEs, biotech's buzzy new financing tool

AstraZeneca loses challenge to Medicare drug price negotiation

In search for therapies for solid tumors, companies turn to claudin

entertainment

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

explore

Bright Health sells Medicare Advantage business to Molina

How to save health care price transparency rules

Medicare details structure of new drug price negotiation program

As AI in medicine takes off, can 'human in the loop' prevent harm?

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Medical device lobby: We're tired of waiting on Medicare coverage

Drug repurposing or repositioning? The language matters

Boston's new lab space is opening empty

The high cost of giving birth even with insurance

Amid AI frenzy, a top HHS official's quest to create safeguards

hotspot

Flu vaccine offering decent levels of protection this winter, new data show

President Biden's budget: Here's what you might have missed

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

International team creates first chimeric human

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

leisure time

explore

focus

focus